Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group. Leahy J, Hickey C, McConnell D, Cassidy O, Trela-Larsen, L, Barry M, Tilson L, McCullagh L. Value in Health 2020. https://doi.org/10.1016/j.jval.2020.09.003
Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study. Cardwell K, Smith S,Clyne B, McCullagh L on behalf of the General Practice Pharmacist (GPP) Study Group, et al. BMJ Open 2020; 10: e035087. doi: 10.1136/bmjopen-2019-035087
A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland. The European Journal of Health Economics. Lamrock F, McCullagh L, Tilson L, Barry M. March 2020. https://doi.org/10.1007/s10198-020-01181-0
The Interaction between Price Negotiations and Heterogeneity: Implications for Economic Evaluations. O’Donnell H, McCullagh L, Barry M, Walsh, C. Medical Decision Making. First Published February, 2020. https://doi.org/10.1177/0272989X19900179
Transferability of Economic Evaluations of Treatments for Advanced Melanoma. Gorry C, McCullagh L, Barry M. PharmacoEconomics (2020) 38:217–231 https://doi.org/10.1007/s40273-019-00860-y
General practitioners’ views on malnutrition management and oral nutritional supplementation prescription in the community: a qualitative study. Dominguez Castro P, Reynolds CME, Kennelly S, Clyne B, Bury G, Hanlon D, Murrin C, McCullagh, L, Finnigan K, Clarke S, Browne S, Perrotta C, Gibney ER, Corish CA. Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2020.01.006
